Avanos Medical [AVNS] vs Axogen [AXGN] Detailed Stock Comparison

Avanos Medical Inc.

NYSE
Loading...

Axogen Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Avanos Medical Inc. wins in 12 metrics, Axogen Inc. wins in 7 metrics, with 0 ties. Avanos Medical Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Avanos Medical Inc. Axogen Inc. Better
P/E Ratio (TTM) 34.37 -110.18 Avanos Medical Inc.
Price-to-Book Ratio 1.47 13.15 Avanos Medical Inc.
Debt-to-Equity Ratio 16.59 55.50 Avanos Medical Inc.
PEG Ratio -0.34 0.04 Axogen Inc.
EV/EBITDA 21.79 -2,165.44 Avanos Medical Inc.
Profit Margin (TTM) -10.40% -6.97% Axogen Inc.
Operating Margin (TTM) 1.99% -16.31% Avanos Medical Inc.
EBITDA Margin (TTM) 1.99% N/A N/A
Return on Equity -9.08% -13.49% Avanos Medical Inc.
Return on Assets (TTM) 0.87% -2.31% Avanos Medical Inc.
Free Cash Flow (TTM) $43.10M $-4.78M Avanos Medical Inc.
1-Year Return 106.28% 341.03% Axogen Inc.
Price-to-Sales Ratio (TTM) 1.64 8.27 Avanos Medical Inc.
Enterprise Value $1.19B $1.89B Axogen Inc.
EV/Revenue Ratio 1.69 8.40 Avanos Medical Inc.
Gross Profit Margin (TTM) 47.54% 74.13% Axogen Inc.
Revenue per Share (TTM) $15 $5 Avanos Medical Inc.
Earnings per Share (Diluted) $-1.57 $-0.34 Axogen Inc.
Beta (Stock Volatility) 1.05 0.98 Axogen Inc.
Short % of Float 6.25% 6.92% Avanos Medical Inc.

Avanos Medical Inc. vs Axogen Inc. Stock Performance Analysis

Loading Price Chart...

AVNS
AXGN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Avanos Medical Inc.0.00%-0.16%1.01%80.61%110.46%123.26%
Axogen Inc.1.72%5.50%6.71%33.19%46.88%41.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Avanos Medical Inc.106.28%-2.50%-37.21%-22.48%-35.57%-35.57%
Axogen Inc.341.03%367.90%106.53%628.81%1,769.57%12,185.71%

Performance & Financial Health Analysis: Avanos Medical Inc. vs Axogen Inc.

MetricAVNSAXGN
Market Information
Market Cap i$1.15B$1.94B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,796,9241,245,238
90 Day Avg. Volume i1,631,7981,068,353
Last Close$24.96$43.74
52 Week Range$9.30 - $25.49$9.22 - $45.83
% from 52W High-2.08%-4.56%
All-Time High$72.96 (Sep 03, 2018)$56.85 (Jul 23, 2018)
% from All-Time High-65.79%-23.06%
Growth Metrics
Quarterly Revenue Growth0.01%0.21%
Quarterly Earnings Growth0.01%0.21%
Financial Health
Profit Margin (TTM) i-0.10%-0.07%
Operating Margin (TTM) i0.02%-0.16%
Return on Equity (TTM) i-0.09%-0.13%
Debt to Equity (MRQ) i16.5955.50
Cash & Liquidity
Book Value per Share (MRQ)$16.75$2.73
Cash per Share (MRQ)$1.93$0.80
Operating Cash Flow (TTM) i$74.70M$812,000
Levered Free Cash Flow (TTM) i$46.01M$3.58M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Avanos Medical Inc. vs Axogen Inc.

MetricAVNS (Apr 24, 2026)AXGN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.37-110.18
Forward P/E i19.7147.31
PEG Ratio i-0.340.04
Price to Sales (TTM) i1.648.27
Price to Book (MRQ) i1.4713.15
Market Capitalization
Market Capitalization i$1.15B$1.94B
Enterprise Value i$1.19B$1.89B
Enterprise Value Metrics
Enterprise to Revenue i1.698.40
Enterprise to EBITDA i21.79-2,165.44
Risk & Other Metrics
Beta i1.050.98
Book Value per Share (MRQ) i$16.75$2.73

Financial Statements Comparison: Avanos Medical Inc. vs Axogen Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAVNS (2025)AXGN (2025)
Revenue/Sales i701.20M225.21M
Cost of Goods Sold i347.30M57.86M
COGS % of Revenue i49.5%25.7%
Gross Profit i353.90M167.35M
Gross Margin i50.5%74.3%
Research & Development i23.30M32.89M
Operating Income (EBIT) i15.40M-7.85M
Operating Margin i2.2%-3.5%
EBITDA i57.50M826,000
EBITDA Margin i8.2%0.4%
Pre-Tax Income i-66.20M-15.70M
Pre-Tax Income % of Revenue i-9.4%-7.0%
Income Tax i6.70MN/A
Income Tax % of Revenue i1.0%0.0%
Net Income (Profit) i-72.90M-15.70M
Profit Margin i-10.4%-7.0%

Balance Sheet & Liquidity Metrics

MetricAVNS (2025)AXGN (2025)
Cash & Equivalents i89.80M35.55M
Total Current Assets i355.40M120.42M
Total Current Assets % of Revenue i50.7%53.5%
Total Current Liabilities i165.20M23.56M
Total Current Liabilities % of Revenue i23.6%10.5%
Long-Term Debt i110.70M65.26M
Long-Term Debt % of Revenue i15.8%29.0%
Total Shareholders Equity i778.20M128.85M
Retained Earnings i-779.90M-306.96M
Retained Earnings % of Revenue i-111.2%-136.3%
Property, Plant & Equipment i27.60M29.38M

Cash Flow Statement Comparison

MetricAVNS (2025)AXGN (2025)
Operating Cash Flow i10.30M10.26M
Operating Cash Flow % of Revenue i1.5%4.6%
Capital Expenditures iN/A-3.75M
Free Cash Flow i43.10M-4.78M
FCF Margin i6.1%-2.1%
Debt Repayment i-34.40M-32,000
Common Stock Repurchase i-3.30MN/A

Short Interest & Institutional Ownership Analysis

MetricAVNSAXGN
Shares Short i2.17M3.50M
Short Ratio i3.754.04
Short % of Float i6.25%6.92%
Shares Outstanding i46.46M47.20M
Float Shares i42.02M50.75M
% Held by Insiders i4.79%2.12%
% Held by Institutions i98.76%88.11%
% Held by Public i-3.55%9.77%

Dividend Analysis & Yield Comparison: Avanos Medical Inc. vs Axogen Inc.

MetricAVNSAXGN
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A